Patents by Inventor William Koenig
William Koenig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240134320Abstract: An asset management system helps ensure the safety of technicians performing maintenance on electrical power generation assets. The system includes an electronic device operated by a technician. Prior to performing maintenance on a power generation asset, the technician utilizes the electronic device to scan an identification marker on the asset. The electronic device then retrieves, from an asset database, status data regarding the safety status of the asset. The electronic device displays the status data to the technician.Type: ApplicationFiled: October 23, 2022Publication date: April 25, 2024Applicant: POWER Engineers, IncorporatedInventors: Christopher William Canine, Charles Mark Koenig
-
Publication number: 20220257622Abstract: The present invention provides compositions and formulations capable of maintaining or promoting the growth of certain strains of Lactobacilli spp. The compositions and formulations generally comprise only a single therapeutic agent selected from the group consisting of isomaltulose, maltitol, pullulan, maltotriose, 2-deoxy-D-ribose, 1-kestose and erlose. The single therapeutic agent is the sole source of carbon for bacterium when administered to a user. Despite comprising only a single therapeutic agent the compositions have been shown to promote the growth and maintenance of beneficial Lactobacilli and to effectively inhibit the growth of pathogens associated with urogenital infections. As such administration of the compositions maintain a healthy microflora balance in the urogenital area.Type: ApplicationFiled: May 6, 2022Publication date: August 18, 2022Inventors: Jingru Li, Lindsay Adrienne Peed, Cheryce Francina Joyner, Rebecca Ann Vongsa, David William Koenig, Ryan Daniel Bartell
-
Patent number: 11383003Abstract: Farnesol analogs, along with their related products (e.g., treatment compositions, wipes, absorbent articles, etc.) and their methods of formation, are provided. The farnesol analog includes a hydrophilic end group (e.g., a hydroxyl end group or a carboxylic acid end group) attached to farnesol via a covalent linkage (e.g., an ester group or an ether group).Type: GrantFiled: January 14, 2020Date of Patent: July 12, 2022Assignee: Kimberly-Clark Worldwide, Inc.Inventors: David William Koenig, Mary Kay Foegen, Corey Thomas Cunningham, Aimin He, Yang Huang
-
Publication number: 20220023322Abstract: The present invention relates to compositions, particularly compositions useful in maintaining and supporting healthy microflora in the female urogenital tract which could lead to inhibition of vaginal infections, as well as methods of treating and preventing vaginal infections. Compositions useful in supporting healthy microflora, disclosed herein, generally comprise a therapeutic amount of a first saccharide and a therapeutic amount of a second saccharide or an organic acid. The saccharides may be, for example, a pentose, a disaccharide, a cyclodextrin, a pectic substance or a non-digestible polysaccharide. The organic acid may be, for example, malic acid.Type: ApplicationFiled: October 8, 2021Publication date: January 27, 2022Inventors: Jingru Li, Lindsay Adrienne Peed, Cheryce Francina Joyner, Rebecca Ann Vongsa, David William Koenig, Ryan Daniel Bartell, Paige Nicole Hollmaier
-
Patent number: 11166968Abstract: The present invention relates to compositions, particularly compositions useful in maintaining and supporting healthy microflora in the female urogenital tract which could lead to inhibition of vaginal infections, as well as methods of treating and preventing vaginal infections. Compositions useful in supporting healthy microflora, disclosed herein, generally comprise a therapeutic amount of a first saccharide and a therapeutic amount of a second saccharide or an organic acid. The saccharides may be, for example, a pentose, a disaccharide, a cyclodextrin, a pectic substance or a non-digestible polysaccharide. The organic acid may be, for example, malic acid.Type: GrantFiled: September 29, 2015Date of Patent: November 9, 2021Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Jingru Li, Lindsay Adrienne Peed, Cheryce Francina Joyner, Rebecca Ann Vongsa, David William Koenig, Ryan Daniel Bartell, Paige Nicole Hollmaier
-
Patent number: 10717946Abstract: Methods for adjusting the solubility of a botanical oil in water, along with the resulting modified botanical oil and related products (e.g., treatment compositions, wipes, absorbent articles, etc.) are provided. In one embodiment, the method includes reacting the botanical oil to form a reactive product (e.g., having a hydroxyl group); and attaching a hydrophilic end group (e.g., a carboxylic acid, a carboxylic acid salt, a sugar, etc.) on the reactive product to form a modified botanical oil. The modified botanical oil generally, in most embodiments, has a greater solubility in water than the botanical oil (e.g., a solubility in water of about 10 grams per 100 grams of water or greater, such as completely soluble in water). The botanical oil includes, in one particular embodiment, an essential oil, such as those essential oil that include at least one terpene compound.Type: GrantFiled: December 27, 2012Date of Patent: July 21, 2020Assignee: Kimberly-Clark Worldside, Inc.Inventors: David William Koenig, Mary Kay Foegen, Corey Thomas Cunningham, Aimin He, Yang Huang
-
Publication number: 20200188551Abstract: Farnesol analogs, along with their related products (e.g., treatment compositions, wipes, absorbent articles, etc.) and their methods of formation, are provided. The farnesol analog includes a hydrophilic end group (e.g., a hydroxyl end group or a carboxylic acid end group) attached to farnesol via a covalent linkage (e.g., an ester group or an ether group).Type: ApplicationFiled: January 14, 2020Publication date: June 18, 2020Inventors: David William Koenig, Mary Kay Foegen, Corey Thomas Cunningham, Aimin He, Yang Huang
-
Patent number: 10589134Abstract: The present disclosure is directed to a system and methods for maintaining or improving hand health and hygiene. More particularly, the system and methods prevent or overcome skin damage caused by frequent hand washing and use of hand sanitizers and/or cleansers. The hand care system comprises an article, such as an elastomeric glove, that has a moisturizing liquid liner composition on the skin-contacting surface of the article that delivers a skin health benefit to the skin, a non-irritating hand cleanser capable of moisturizing the skin, and a moisturizing hand sanitizer.Type: GrantFiled: January 30, 2008Date of Patent: March 17, 2020Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Douglas Robert Hoffman, Scott W. Wenzel, David William Koenig, Lisa Flugge-Berendes
-
Patent number: 10532124Abstract: Farnesol analogs, along with their related products (e.g., treatment compositions, wipes, absorbent articles, etc.) and their methods of formation, are provided. The farnesol analog includes a hydrophilic end group (e.g., a hydroxyl end group or a carboxylic acid end group) attached to farnesol via a covalent linkage (e.g., an ester group or an ether group).Type: GrantFiled: December 27, 2012Date of Patent: January 14, 2020Assignee: Kimberly-Clark Worldwide, Inc.Inventors: David William Koenig, Mary Kay Foegen, Corey Thomas Cunningham, Aimin He, Yang Huang
-
Patent number: 10441603Abstract: The present invention relates to prebiotic compositions and formulations comprising an ?-hydroxy acid and salts thereof, such as lactic, glycolic, citric, tartaric or malic acid and a prebiotic agent, such as inulin, fructo-oligosaccharide (FOS), lactulose, galacto-oligosaccharide (GOS), raffinose, stachyose, isomalto-oligosaccharide, and xylo-oligosaccharide. Prebiotic compositions of the present invention provide a surprisingly synergist prebiotic effect and may be administered in several forms to a user, such as by application to a premoistened wiping substrate or dry bath tissue.Type: GrantFiled: September 30, 2014Date of Patent: October 15, 2019Assignee: KIMBERLY-CLARK WORLDWIDE, INC.Inventors: David William Koenig, Michael Andrew Zawadzki, Cathleen Mae Uttecht, Jeffrey Janne Johnson, David Andrew Moline, Rebecca Ann Vongsa, Amy Lynn Vanden Heuvel, YoungSook Kim, SangHa Park, Jessica Caroline Rogers
-
Patent number: 10327956Abstract: A wound dressing system comprising a wrap and a frangible ampoule is provided. The wrap is configured to contact/surround a wound site and includes an oxygen catalyst. The ampoule includes an oxygen precursor. The catalyst and precursor are configured to form oxygen when combined. A wound dressing system including a container is also provided that includes a powder, wrap, and frangible ampoule. The powder is disposed within the container, which is configured to allow the powder to be dispersed onto a wound site when activated. The wrap, which may include an oxygen catalyst, is also disposed in the container and is configured to contact/surround the wound site. The ampoule, also disposed in the container, includes a liquid containing an oxygen precursor. The liquid is configured to contact the wrap when the container is activated. Further, the catalyst and precursor are configured to form oxygen when combined.Type: GrantFiled: January 23, 2015Date of Patent: June 25, 2019Assignee: Avent, Inc.Inventors: John Gavin MacDonald, Kelly Dean Branham, David William Koenig, Andrew V. Sweeney, Stephanie Kute, Ramanathan S. Lalgudi, Phillip Andrew Schorr, Alison Salyer Bagwell, Brian Joseph Cuevas, David James McNamara
-
Publication number: 20180256615Abstract: The present invention provides compositions and formulations capable of maintaining or promoting the growth of certain strains of Lactobacilli spp. The compositions and formulations generally comprise only a single therapeutic agent selected from the group consisting of isomaltulose, maltitol, pullulan, maltotriose, 2-deoxy-D-ribose, 1-kestose and erlose. The single therapeutic agent is the sole source of carbon for bacterium when administered to a user. Despite comprising only a single therapeutic agent the compositions have been shown to promote the growth and maintenance of beneficial lactobacilli and to effectively inhibit the growth of pathogens associated with urogenital infections. As such administration of the compositions maintain a healthy microflora balance in the urogenital area.Type: ApplicationFiled: September 29, 2015Publication date: September 13, 2018Inventors: Jingru LI, Lindsay Adrienne PEED, Cheryce Francina JOYNER, Rebecca Ann VONGSA, David William KOENIG, Ryan Daniel BARTELL
-
Publication number: 20180250318Abstract: The present invention relates to compositions, particularly compositions useful in maintaining and supporting healthy microflora in the female urogenital tract which could lead to inhibition of vaginal infections, as well as methods of treating and preventing vaginal infections. Compositions useful in supporting healthy microflora, disclosed herein, generally comprise a therapeutic amount of a first saccharide and a therapeutic amount of a second saccharide or an organic acid. The saccharides may be, for example, a pentose, a disaccharide, a cyclodextrin, a pectic substance or a non-digestible polysaccharide. The organic acid may be, for example, malic acid.Type: ApplicationFiled: September 29, 2015Publication date: September 6, 2018Inventors: Jingru Li, Lindsay Adrienne Peed, Cheryce Francina Joyner, Rebecca Ann Vongsa, David William Koenig, Ryan Daniel Bartell, Paige Nicole Hollmaier
-
Publication number: 20180207313Abstract: An extruded water-soluble article is made from homogeneous material that includes a water-soluble polymer having an extrusion temperature of 50 to 150° C. This relatively low extrusion temperature is compatible with actives that would otherwise be destroyed in a high temperature extrusion process. The article further includes between 0.1% to 50% by weight of an active agent.Type: ApplicationFiled: April 1, 2015Publication date: July 26, 2018Inventors: Shiming Zhuang, Rebecca Ann Vongsa, Peiguang Zhou, Andrew Mark Long, David William Koenig, David J. Tyrell, Paige N. Anunson
-
Patent number: 10022308Abstract: The present invention relates to methods and products, such as wet wipes and absorbent articles, that are capable of imparting a health benefit when used in the intended fashion. More specifically, the products described herein comprise one or more botanical compounds, which are capable of selectively controlling the balance of flora on the skin. The compounds may enhance the adherence of healthy flora to the surface of skin or mucosa, inhibit the growth of problem flora on or around the skin surface, or inhibit the adherence of problem flora to the surface of skin or mucosa, or any combination thereof.Type: GrantFiled: August 22, 2014Date of Patent: July 17, 2018Assignee: Kimberly-Clark Worldwide, Inc.Inventors: David William Koenig, Beth A. Lange, Christine L. Schneider
-
Patent number: 9826876Abstract: A cleaning article includes a cleaning article sheet comprising a fabric substrate, wherein the fabric substrate includes pores therein, and wherein the fabric substrate has a background moisture percentage by weight, and liquid water disposed substantially and disconnectedly within the pores, wherein the liquid water is at moisture percentage by weight that is 5 to 150 percentage points higher than the background moisture percentage. The nonwoven substrate can include pores formed between and/or within the fibers and can have a background moisture percentage by weight. The substrate can include a treatment to increase the dielectric constant from the dielectric constant of the substrate without the treatment. The moisture of the article can be configured to exhibit a dielectric constant of at least 50% and up to 600% higher than the dielectric constant of the same article with only background moisture.Type: GrantFiled: September 30, 2013Date of Patent: November 28, 2017Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Kaiyuan Yang, Andrew T Baker, Joseph R Feldkamp, David William Koenig, WanDuk Lee, Carl G Rippl, Kathleen C Engelbrecht, Waihong Leong, Dave A Soerens, Divesh Bhatt, Jin Heo, Jose Kollakompil Abraham
-
Publication number: 20170258823Abstract: The present invention relates to prebiotic compositions and formulations comprising an ?-hydroxy acid and salts thereof, such as lactic, glycolic, citric, tartaric or malic acid and a prebiotic agent, such as inulin, fructo-oligosaccharide (FOS), lactulose, galacto-oligosaccharide (GOS), raffinose, stachyose, isomalto-oligosaccharide, and xylo-oligosaccharide. Prebiotic compositions of the present invention provide a surprisingly synergist prebiotic effect and may be administered in several forms to a user, such as by application to a premoistened wiping substrate or dry bath tissue.Type: ApplicationFiled: September 30, 2014Publication date: September 14, 2017Inventors: David William Koenig, Michael Andrew Zawadzki, Cathleen Mae Uttecht, Jeffrey Janne Johnson, David Andrew Moline, Rebecca Ann Vongsa, Amy Lynn Vanden Heuvel, YoungSook Kim, SangHa Park, Jessica Caroline Rogers
-
Patent number: 9744248Abstract: The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile strength, stiffness or softness. Thus, in certain embodiments the present invention provides soft, durable creped prebiotic tissue products that are able to improve the growth of healthy bacteria such as Bifidobacterium spp. or Lactobacillus spp. without promoting growth of enteropathogenic bacteria. The tissue products provide these benefits yet have a GMT greater than about 500, a Stiffness Index less than about 20 and a TS7 value less than about 10.Type: GrantFiled: December 2, 2016Date of Patent: August 29, 2017Assignee: KIMBERLY-CLARK WORLDWIDE, INC.Inventors: Michael Andrew Zawadzki, Jeffrey Janne Johnson, David William Koenig, Amy Lynn Vanden Heuvel, David Andrew Moline, Rebecca Ann Vongsa, Cathleen Mae Uttecht, Donald Eugene Waldroup
-
Patent number: 9648875Abstract: Formulations and wipes for imparting a sporicide to a surface are disclosed herein. To achieve the sporicidal efficacy of the product, a synergistic amount of an amine oxide surfactant and a mixture of oxidants is incorporated into the formulation. The operative sporicidal formulation contains a solvent, an amine oxide surfactant, a water soluble oxidant and a water insoluble oxidant. Typically, the formulation can contain about 0.05 to about 3.7 percent (by weight of the formulation) of an amine oxide surfactant, about 0.5 to about 4 percent (by weight of the formulation) of a water soluble oxidant, and about 0.1 to about 6 percent (by weight of the formulation) of a water insoluble oxidant.Type: GrantFiled: October 28, 2011Date of Patent: May 16, 2017Assignee: Kimberly-Clark Worldwide, Inc.Inventors: David William Koenig, Douglas Robert Hoffman, Yang Huang, Aimin He
-
Patent number: D790342Type: GrantFiled: May 5, 2015Date of Patent: June 27, 2017Assignee: The Procter & Gamble CompanyInventors: Michael Sean Farrell, William Michael Cannon, John William Koenig